Introduction
Methods
Patients and controls
Study protocol
Measures of atherosclerosis
Laboratory analyses
Statistical methods
Patients (n= 111) | Controls (n= 105) | Pvalue | |
---|---|---|---|
Age, years | 61.8 ± 12.5 | 61.5 ± 12.3 | ns |
Gender female % (n) | 81 (90) | 86 (90) | ns |
Disease characteristics
| |||
Disease duration (years) | 9.4 (5.6-17.4) | - | - |
Diffuse cutaneous % (n) Limited cutaneous % (n) | 22 (24) 78 (87) | - - | - |
Pulmonary fibrosis % (n) | 46 (51) | - | - |
Suspected pulmonary hypertension % (n) | 15 (17) | 0 | - |
Raynaud % (n) | 95 (105) | 11 (12) | - |
Digital ulcers ever % (n) | 39 (43) | 0 | - |
Calcinosis % (n) | 27 (30) | 0 | - |
Myositis % (n) | 9 (10) | 0 | - |
Arthritis % (n) | 29 (32) | 4 (4) | - |
Kidney involvement % (n) | 7 (8) | 0 | - |
Skin score | 6 (3-10) | 0 | - |
Disease activity | 0.5 (0-2) | - | - |
Disease severity | 5 (3-6) | - | - |
Autoantibodies
Anticentromere (ACA) % (n) Antitopoisomerase 1 (ATA) % (n) Antinuclear (ANA) neg % (n) | 32 (35) 23 (25) 7 (8) | - - - | |
Traditional cardiovascular risk factors
| |||
Body mass index (kg/m2) | 24.2 ± 3.80 | 26.0 ± 3.7 | 0.0005 |
Waist-hip ratio | 0.83 ± 0.09 | 0.84 ± 0.08 | ns |
Ever smoked % (n) Current smoker % (n) | 53 (59) 11 (12) | 44 (46) 7 (7) | ns ns |
Systolic BP (mmHg) Diastolic BP (mmHg) Hypertension % (n) | 123.18 ± 17.94 71.63 ± 10.65 30 (33) | 124.09 ± 18.59 74.5 ± 9.49 20 (21) | ns 0.04 ns |
P-glucose (mmol/l) Diabetes % (n) | 5.45 ± 1.17 6 (7) | 5.43 ± 1.34 7 (7) | ns ns |
Cholesterol (mmol/l) LDL (mmol/l) HDL (mmol/l) Triglycerides (mmol/l) | 5.20 ± 1.04 3.32 ± 0.93 1.3 (1.0-1.5) 0.99 (0.76-1.5) | 5.24 ± 1.15 3.37 ± 0.91 1.4 (1.2-1.7) 0.93 (0.67-1.3) | ns ns ns (0.09) 0.03 |
Inflammatory biomarkers
| |||
hsCRP (mg/l) | 2.2 (1.0-4.3) | 1.75 (0.76-3.2) | 0.05 |
Orosomucoid (g/l) | 0.86 ± 0.23 | 0.77 ± 0.17 | 0.0009 |
Alpha1antitrypsine (g/l) | 1.5 (1.4-1.6) | 1.4 (1.2-1.5) | <0.0001 |
Fibrinogen (g/l) | 3.77 (3.3-4.34) | 3.53 (2.80-4.25) | 0.03 |
Sedimentation rate (mm) Interleukin-6 (pg/ml) | 14 (9-26) 29.9 (21.4-40.9) | 10 (7-16.5) 27.1 (21.2-32.5) | 0.002 ns (0.08) |
Endothelial biomarkers
| |||
VCAM-1 (ng/l) | 698 (546-807) | 531 (431-719) | <0.0001 |
ICAM-1 (ng/l) | 376 (314-472) | 330 (254-450) | 0.002 |
VEGF (pg/ml) | 182 (143-258) | 156 (103-239) | 0.009 |
vWF (IU/ml) | 1.25 (0.90-1.70) | 0.85 (0.58-1.36) | <0.0001 |
Renal function
| |||
eGFR (mL/min/1.73 m2) | 74 (50-116) | 104 (89-126) | 0.01 |
Results
Basic characteristics
Occurrence of ischemic arterial events and measures of atherosclerosis
Patients (n= 111) | Controls (n= 105) | Odds ratio (95% CI) | Pvalue | |
---|---|---|---|---|
Any arterial event % (n) | 18 (20) | 7 (7) |
3.1 (1.2-7.6)
|
0.01
|
IHD % (n) | 12 (13) | 4 (4) |
3.3 (1.1-10.6)
|
0.03
|
ICVD % (n) | 3 (4) | 3 (3) | 0.9 (0.2-4.7) | ns |
IPVD % (n) | 8 (9) | 1 (1) |
9.2 (1.1-73.7)
|
0.02
|
Plaques % (n) | 48 (52) | 41 (43) | 1.3 (0.7-2.3) | ns |
β-coefficient
| ||||
IMT mm | 0.68 ± 0.13 | 0.68 ± 0.13 | -0.02 | ns |
ABI
| 1.13 (1.1-1.2) | 1.12 (1.1-1.2) | -0.08 | ns |
Risk factors for ischemic arterial events
Any event (n= 20) | IHD (n= 13) | IPVD (n= 9) | ||||
---|---|---|---|---|---|---|
Odds ratio (95% CI) | Pvalue | Odds ratio (95% CI) | Pvalue | Odds ratio (95% CI) | Pvalue | |
Age | 1.10 (1.05-1.17) | <0.0001 | 1.06 (1.01-1.13) | 0.02 | 1.13 (1.05-1.26) | 0.0005 |
Associations after adjustment for age | ||||||
Kidney disease |
8.8 (1.5-55.8)
|
0.01
|
6.6 (1.12-36.15)
|
0.04
| ND | 0.3 |
Skin score |
1.13 (1.03-1.24)
|
0.008
| 1.07 (0.97-1.18) | 0.1 |
1.16 (1.02-1.32)
|
0.02
|
Disease severity |
1.29 (1.05-1.62)
|
0.02
| 1.11 (0.88-1.39) | 0.4 | 1.15 (0.85-1.55) | 0.3 |
ACA+ |
3.61 (1.21-11.3)
|
0.02
| 1.9 (0.55-6.45) | 0.2 | 6.8 (1.37-45.3) |
0.02
|
ATA+ | 0.18 (0.01-1.01) | 0.05 |
0.00003 (0-0.6)
|
0.01
| 0.83 (0.04-5.67) | 0.9 |
VCAM-1 | 5.30 (0.51-62.1) | 0.2 |
27.3 (2.52-427. 4)
|
0.005
| 0.37 (0.02-5.46) | 0.2 |
VEGF | 0.68 (0.24-1.84) | 0.4 |
0.29 (0.09-0.93)
|
0.03
| 0.52 (0.12-2.33) | 0.4 |
eGFR |
0.26 (0.10-0.62)
|
0.003
|
0.32 (0.12-0.81)
|
0.02
| 0.57 (0.15-3.65) | 0.5 |
Risk factors for atherosclerosis
Plaques (n= 52) | IMT | ABI | ||||
---|---|---|---|---|---|---|
Odds ratio (95% CI) | Pvalue | β-coefficient | Pvalue | β-coefficient | P value | |
Age | 1.09 (1.05-1.14) | <0.0001 | 0.66 | <0.0001 | -0.20 | 0.03 |
Associations after adjustment for age | ||||||
Gender female | 0.39 (0.12-1.18) | 0.1 |
-0.19
|
0.0001
| -0.12 | 0.2 |
ACA+ |
2.9 (1.2-7.5)
|
0.02
| -0.01 | 0.9 | -0.14 | 0.2 |
Digital ulcers |
2.6 (1.1-6.6)
|
0.03
| 0.10 | 0.2 | -0.09 | 0.4 |
Kidney disease |
11.5 (1.7-232)
|
0.03
| -0.05 | 0.5 | 0.05 | 0.6 |
Disease activity |
1.6 (1.04-2.5)
|
0.03
| 0.10 | 0.2 |
-0.34
|
0.0004
|
Disease severity |
1.3 (1.1-1.5)
|
0.005
| 0.12 | 0.1 | 0.13 | 0.2 |
Waist-hip ratio | 2.6 (0.01-645) | 0.7 | 0.09 | 0.2 |
0.19
|
0.04
|
Ever smoked |
2.5 (1.05-6.7)
|
0.04
| 0.10 | 0.2 |
0.24
|
0.01
|
Systolic BP |
1.0 (1.0-1.1)
|
0.02
|
0.28
|
0.0008
| -0.06 | 0.6 |
Diastolic BP |
1.1 (1.0-1.1)
|
0.008
| 0.13 | 0.1 | -0.02 | 0.9 |
Interleukin-6 |
3.5 (1.5-9.3)
|
0.003
| 0.12 | 0.1 | -0.13 | 0.2 |
VCAM-1 |
9.4 (1.8-58.3)
|
0.008
| -0.05 | 0.5 | 0.03 | 0.8 |
ICAM-1 | 0.32 (0.05-1.98) | 0.2 |
0.16
|
0.04
| -0.12 | 0.2 |
eGFR |
0.4 (0.2-0.99)
|
0.04
| 0.11 | 0.2 | -0.04 | 0.7 |
Plaques | ||
---|---|---|
Functional groups and included variables | Odds ratio (95% CI) | Pvalue |
Age |
1.1 (1.03-1.16)
|
0.003
|
Disease characteristics
| ||
ACA+ |
4.0 (1.26-14.1)
|
0.02
|
Traditional risk factors
| ||
Diastolic blood pressure (mmHg) |
1.1 (1.01-1.11)
|
0.04
|
Inflammatory biomarkers
| ||
IL-6 (pg/ml) |
3.8 (1.3-13.3)
|
0.01
|
Endothelial biomarkers
| ||
VCAM-1 (ng/ml) | 1.5 (0.15-14.7) | 0.7 |
Kidney function test
| ||
eGFR (mL/min/1.73 m2) | 0.3 (0.04-1.07) | 0.07 |
Subgroup analysis of ACA+ SSc patients
Occurrence of events and atherosclerosis | ACA+ vs. ACA- | ACA+ vs. controls | |||||
---|---|---|---|---|---|---|---|
ACA+ (n= 34) | ACA- (n= 77) | Controls (n= 105) | Odds ratio** (95% CI) | Pvalue** | Odds ratio* (95% CI) | Pvalue* | |
Any arterial event % (n) | 32 (11) | 11 (9) | 7 (7) |
5.1 (1.57-18.6)
|
0.01
|
8.5 (2.6-31.7)
|
0.0003
|
IHD % (n) | 18 (6) | 9 (7) | 4 (4) | 2.6 (0.7-10.0) | 0.2 |
4.8 (1.2-20.7)
|
0.02
|
ICVD % (n) | 6 (2) | 3 (2) | 3 (3) | 4.0 (0.4-49.0) | 0.2 | 2.0 (0.2-13.9) | 0.6 |
IPVD % (n) | 18 (6) | 4 (3) | 1 (1) |
9.1 (1.6-79.1)
|
0.01
|
70.1 (6.5-2524)
|
<0.0001
|
Plaque % (n) | 65 (22) | 39 (30) | 41 (43) |
3.1(1.2-8.5)
|
0.02
|
2.8 (1.1-7.6)
|
0.04
|
β-coefficient
|
β-coefficient
| ||||||
IMT mm | 0.69 ± 0.13 | 0.68 ± 0.13 | 0.68 ± 0.13 | 0.03 | 0.7 | 0.01 | 0.6 |
ABI | 1.1(1.03-1.2) | 1.1 (1.17-1.2) | 1.1 (1.07-1.2) | -0.12 | 0.08 | -0.14 | 0.07 |